Outcome of 212 malignant phyllod tumor patients: A retrospective study from the French Sarcoma Group (GSF-GETO).

Mathias Neron,Christophe Sajous,Sophie Piperno-Neumann,Camille Chakiba,Agnès Ducoulombier,Clémentine Owen,S Bastien Salas,François Bertucci,Esma Saada-Bouzid,Thibaud Valentin,Jacques-Olivier Bay,Emmanuelle Bompas,Nicolas Isambert,Aurélie Maran-Gonzalez,C. Llacer,S. Carrere,Didier Cupissol,Simon Thezenas,Jean-Yves Blay,Nelly Firmin

Outcome of 212 malignant phyllod tumor patients: A retrospective study from the French Sarcoma Group (GSF-GETO).

2017

11055Background: The optimal management of malignant phyllod tumors (MPT) is poorly documented. Objective:To study the characteristics and outcome of MPT patients (pts). Methods: Retrospective stud...

Keywords:

Retrospective cohort study
Pathology
Sarcoma
Medicine
Oncology
optimal management
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations